| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs540266824 |
chr1:243040584-243040585 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 2 |
rs553475930 |
chr1:243040613-243040614 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs576559011 |
chr1:243040615-243040616 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs115457617 |
chr1:243040629-243040630 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs12097996 |
chr1:243040659-243040660 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 6 |
rs531751367 |
chr1:243040670-243040671 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs542014606 |
chr1:243040726-243040727 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs562444458 |
chr1:243040765-243040766 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs4658370 |
chr1:243040780-243040781 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 10 |
rs185360877 |
chr1:243040821-243040822 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs570725377 |
chr1:243040829-243040830 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs542216525 |
chr1:243040839-243040840 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs533478776 |
chr1:243040860-243040861 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs188997791 |
chr1:243040895-243040896 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs144281822 |
chr1:243040905-243040906 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs538086223 |
chr1:243040909-243040910 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs554459686 |
chr1:243040916-243040917 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs180845933 |
chr1:243040923-243040924 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs12032023 |
chr1:243040970-243040971 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 20 |
rs76531328 |
chr1:243040997-243040998 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs186488559 |
chr1:243041025-243041026 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs4658504 |
chr1:243041047-243041048 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 23 |
rs111610464 |
chr1:243041064-243041065 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs79725943 |
chr1:243041066-243041067 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs535376760 |
chr1:243041112-243041113 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs35389501 |
chr1:243041115-243041116 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs542443199 |
chr1:243041121-243041122 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs191328084 |
chr1:243041159-243041160 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs556173118 |
chr1:243041209-243041210 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs572720883 |
chr1:243041253-243041254 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs541325708 |
chr1:243041279-243041280 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs564478748 |
chr1:243041281-243041282 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs562122547 |
chr1:243041309-243041310 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs564959611 |
chr1:243041465-243041466 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs554960138 |
chr1:243041510-243041511 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs550197752 |
chr1:243041545-243041546 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs563815739 |
chr1:243041596-243041597 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs529393374 |
chr1:243041646-243041647 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs377024817 |
chr1:243041663-243041664 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs548395960 |
chr1:243041729-243041730 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs182952493 |
chr1:243041813-243041814 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs185724173 |
chr1:243041826-243041827 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs12059612 |
chr1:243041828-243041829 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 44 |
rs142393529 |
chr1:243041931-243041932 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs190923226 |
chr1:243041952-243041953 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs575759512 |
chr1:243041964-243041965 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs535173316 |
chr1:243042012-243042013 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs115723888 |
chr1:243042036-243042037 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs534312721 |
chr1:243042130-243042131 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs183069923 |
chr1:243042131-243042132 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|